Zycov-d Vaccine By Zydus Cadila
- All
- News
- Videos
-
Zydus Cadila Agrees To Reduce Covid Vaccine Price To Rs 265 Per Dose: Report
Zydus Cadila's ZyCov-D is the first vaccine cleared by India's drug regulator for inoculation of those aged 12 years and above
-
Zydus Cadila's ZyCoV-D To Be Introduced In Covid Vaccine Drive Shortly: Centre
The government today said Zydus Cadila's indigenously-developed needle-free Covid vaccine ZyCoV-D will be introduced in the nationwide vaccination drive very shortly and will be differentially priced than the jabs being used currently.
-
Stocks To Watch: Cadila Healthcare, Infosys, HDFC Bank
Zydus Cadila's Covid vaccine, ZyCoV-D, has received approval for emergency use authorization from the Drug Controller General of India
-
Zydus Cadila Says "More Clarity" On Its Covid Vaccine Price By Next Week
There will be more clarity on the prices of COVID-19 vaccine ZyCOV-D by next week, Zydus Group Managing Director Dr Sharvil Patel said today.
-
Zydus To Produce 1 Crore Doses Per Month By October, Says Chief
Zydus Cadila, whose Covid vaccine ZyCoV-D for adults and children aged 12 years and above got approval yesterday, said it hopes to produce one crore doses per month by October.
-
"3 Doses, 66 Per Cent Efficacy": 5 Things To Know About Zydus Cadila's Covid Vaccine For Children
Zydus Cadila's Covid vaccine ZyCoV-D, meant for adults and children aged 12 years and above, was today approved for "restricted use in emergency situation" by the Central Drugs Standard Control Organisation (CDSCO).
-
India's Zydus Cadila Seeks Nod For Its 3-Dose, "Needle-Free" Vaccine
Zydus Cadila has requested emergency use approval for its ZyCoV-D three-dose Covid shot that is the "world's first Plasmid DNA vaccine". The shot is "needle-free", says the company, and "safe for children".
-
Stocks To Watch: Cadila Healthcare, SpiceJet, Vodafone Idea
Zydus Cadila has applied for Emergency Use Authorization to the office of Drug Controller General of India for ZyCoV-D - its Plasmid DNA vaccine against COVID-19
-
Zydus Cadila's COVID-19 Vaccine Candidate Found Safe In Early-Stage Human Trial
Zydus plans to complete late-stage trials for ZyCoV-D by February or March and could produce up to 100 million doses a year initially.
-
Cadila Aims To Complete Trial Of Coronavirus Vaccine By March
Coronavirus vaccine: Early-stage Phase 1 and 2 human trials are likely to be concluded in the next three months
-
Zydus Cadila Agrees To Reduce Covid Vaccine Price To Rs 265 Per Dose: Report
Zydus Cadila's ZyCov-D is the first vaccine cleared by India's drug regulator for inoculation of those aged 12 years and above
-
Zydus Cadila's ZyCoV-D To Be Introduced In Covid Vaccine Drive Shortly: Centre
The government today said Zydus Cadila's indigenously-developed needle-free Covid vaccine ZyCoV-D will be introduced in the nationwide vaccination drive very shortly and will be differentially priced than the jabs being used currently.
-
Stocks To Watch: Cadila Healthcare, Infosys, HDFC Bank
Zydus Cadila's Covid vaccine, ZyCoV-D, has received approval for emergency use authorization from the Drug Controller General of India
-
Zydus Cadila Says "More Clarity" On Its Covid Vaccine Price By Next Week
There will be more clarity on the prices of COVID-19 vaccine ZyCOV-D by next week, Zydus Group Managing Director Dr Sharvil Patel said today.
-
Zydus To Produce 1 Crore Doses Per Month By October, Says Chief
Zydus Cadila, whose Covid vaccine ZyCoV-D for adults and children aged 12 years and above got approval yesterday, said it hopes to produce one crore doses per month by October.
-
"3 Doses, 66 Per Cent Efficacy": 5 Things To Know About Zydus Cadila's Covid Vaccine For Children
Zydus Cadila's Covid vaccine ZyCoV-D, meant for adults and children aged 12 years and above, was today approved for "restricted use in emergency situation" by the Central Drugs Standard Control Organisation (CDSCO).
-
India's Zydus Cadila Seeks Nod For Its 3-Dose, "Needle-Free" Vaccine
Zydus Cadila has requested emergency use approval for its ZyCoV-D three-dose Covid shot that is the "world's first Plasmid DNA vaccine". The shot is "needle-free", says the company, and "safe for children".
-
Stocks To Watch: Cadila Healthcare, SpiceJet, Vodafone Idea
Zydus Cadila has applied for Emergency Use Authorization to the office of Drug Controller General of India for ZyCoV-D - its Plasmid DNA vaccine against COVID-19
-
Zydus Cadila's COVID-19 Vaccine Candidate Found Safe In Early-Stage Human Trial
Zydus plans to complete late-stage trials for ZyCoV-D by February or March and could produce up to 100 million doses a year initially.
-
Cadila Aims To Complete Trial Of Coronavirus Vaccine By March
Coronavirus vaccine: Early-stage Phase 1 and 2 human trials are likely to be concluded in the next three months
